Breaking News

Mumbai firm may become first in India to develop anti-retroviral drug for Covid-19


In a sign of innovation in prescribed drugs for Covid, Mumbai-based Glenmark may become the primary company in India to supply an anti-retroviral, Favipiravir, from a class of drugs which has proven promise, and is being used as a potential treatment for the virus. Glenmark has evolved anti-retroviral (ARV) drug, Favipiravir, which has proven positive effects globally, and has applied for regulatory acclaim for trials in India, sources instructed TOI.


No comments